The global impact of SARS-CoV-2 variant BA.2.86: a comprehensive analysis with the latest developments and transmission trends - an epidemiological study
CONCLUSIONS: The SARS-CoV-2, novel variant BA.2.86, spread over six continents and 89 countries and affected 19,532 people worldwide. The disease is more prevalent in the United Kingdom, United States of America, and European countries. The detection of the disease in multiple continents and countries suggests some degree of transmissibility. Global health authorities need to rethink their policies and implement strict strategies to eradicate emerging variants and minimize the global disease burden.PMID:38639533 | DOI:10.26355/eurrev_202404_35928
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Authors: S A Meo A S Meo D M Halepoto Source Type: research
More News: African Health | Australia Health | Canada Health | Coronavirus | COVID-19 | Denmark Health | Drugs & Pharmacology | Epidemiology | France Health | Germany Health | Influenza | International Medicine & Public Health | Japan Health | Netherlands Health | Respiratory Medicine | SARS | Science | South Korea Health | Spain Health | Study | Sweden Health | UK Health | USA Health | WHO